Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
China
Regenerative Medicine Center and Red Blood Cell Disorders Center, Tianjin, Tianjin Municipality Age range
12 Years and older
Last updated December 2024